false
Catalog
The Liver Meeting 2019
Rationale for Surveillance in HCC for Patients wit ...
Rationale for Surveillance in HCC for Patients with NASH/Metabolic Syndrome
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video transcript, Dr. Elisabetta Bugianesi discusses the rationale for surveillance in hepatocellular carcinoma (HCC) for patients with NASH and metabolic syndrome. She highlights the importance of identifying high-risk patients and factors influencing the utility of surveillance, such as diagnostic tests and treatment availability. Dr. Bugianesi explains the progression from NAFLD to HCC, emphasizing the impact of obesity, insulin resistance, genetic modifiers, and lifestyle factors. She discusses the challenges of non-invasive tests for stratifying HCC risk in NAFLD and the need for clear epidemiological data and reliable tools for surveillance. Lifestyle interventions, like the Mediterranean diet and physical activity, are recommended for preventing HCC in NAFLD patients. Additionally, the potential role of drugs like metformin and statins in reducing HCC risk is mentioned.
Asset Caption
Presenter: Elisabetta Bugianesi
Keywords
surveillance in hepatocellular carcinoma
NASH
metabolic syndrome
high-risk patients
diagnostic tests
treatment availability
×
Please select your language
1
English